MetLife Investment Management’s Palladyne AI PDYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$110K Buy
+18,068
New +$122K ﹤0.01% 2495
2025
Q4
Sell
-9,729
Closed -$83.6K 2885
2025
Q3
$83.6K Sell
9,729
-6,724
-41% -$55.8K ﹤0.01% 2722
2025
Q2
$142K Buy
+16,453
New +$117K ﹤0.01% 2363
2022
Q4
Sell
-11,062
Closed -$147K 2847
2022
Q3
$147K Buy
11,062
+3,390
+44% +$63.4K ﹤0.01% 2472
2022
Q2
$122K Buy
+7,672
New +$190K ﹤0.01% 2618

Other funds holding PDYN

MetLife Investment Management's PDYN Position: Q1 2026 in Review

MetLife Investment Management opened a new position in Palladyne AI (PDYN) in Q1 2026: 18,068 shares worth $110K. The stake represents ﹤0.01% of the portfolio and ranks #2495 among its holdings. This is a return to the name: MetLife Investment Management previously reported a position in PDYN as recently as Q3 2025.

MetLife Investment Management first reported a position in PDYN in Q2 2022 and has held it in 5 quarters since. The position peaked at $147K in Q3 2022. 118 funds tracked by Wall St. Rank hold PDYN as of Q1 2026.

  • MetLife Investment Management held 18,068 shares of Palladyne AI worth $110K as of Q1 2026.
  • Palladyne AI was a new MetLife Investment Management position in Q1 2026.
  • Palladyne AI made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2495 holding.
  • MetLife Investment Management first reported a position in Palladyne AI in Q2 2022 and has held it in 5 quarters since.
  • MetLife Investment Management's Palladyne AI position peaked at $147K in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Palladyne AI as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.